CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) SPECT and PET in ischemic heart failure

Original ResearchVolume 7, Issue 6, June 2019

JOURNAL:JACC: Heart Failure Article Link

Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF

C Balmforth, J Simpson, L Shen et al. Keywords: angiotensin receptor blocker; angiotensin-converting enzyme inhibitor; etiology; heart failure; natriuretic peptide; sneprilysin; treatment

FULL TEXT PDF